Review and clinical perspectives for the use of infliximab in ulcerative colitis

Infliximab is a chimeric, monoclonal anti-tumour necrosis factor-alpha antibody. It has been previously demonstrated to be an effective treatment for patients with Crohn’s disease who do not achieve the desired response with conventional treatments. Although the etiology of ulcerative colitis (UC) d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Panaccione, Remo, Fedorak, Richard N, Aumais, Guy, Bernard, Edmond-Jean, Bernstein, Charles N, Bitton, Alain, Croitoru, Ken, Dieleman, Levinus A, Enns, Robert, Feagan, Brian G, Franchimont, Denis, Greenberg, Gordon R, Griffiths, Anne-Marie, Marshall, John K, Pare, Pierre, Patel, Sunil, Penner, Robert, Render, Craig, Seidman, Ernest, Steinhart, A Hillary
Formato: Artigo
Idioma:Inglês
Publicado em: Pulsus Group Inc 2008
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2662201/
https://ncbi.nlm.nih.gov/pubmed/18354755
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados